NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 212800000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2024-03-31)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2025-06-30
Retrieved: 2026-08-23T23:02:05.150702+02:00
Raw response sha256: c8e95e08e2a4ef338b66b87733882a24…
Cite as: FACTANKER, https://factanker.com/fact/8c09313c-8096-4044-b0eb-d7dcdbe7a7d2

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies